| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |